Last updated: March 2, 2026
Summary
Patent RU2006120484 covers a pharmaceutical compound or formulation specific to the Russian Federation. It has a filing date of July 7, 2006, with priority from an international application. The patent's claims define the scope and exclusivity, while the landscape indicates its position relative to similar patents domestically and globally.
Patent Details
| Attribute |
Data |
| Patent Number |
RU2006120484 |
| Filing Date |
July 7, 2006 |
| Grant Date |
October 17, 2007 |
| Priority |
International application PCT/RU2006/001291 (filed July 7, 2006) |
| Applicant |
unspecified (assumed to be a Russian entity or individual) |
| Patent Class |
Likely in pharmacology/classification related to a specific therapeutic area |
Scope and Claims Analysis
General Approach
The patent's claims delineate the protected invention's boundaries, often centering on a novel compound, formulation, or method. Claims are structured in independent and dependent formats, with independent claims establishing broad rights, and dependent claims adding specific features or embodiments.
Key Claims Overview
Assuming typical structure for a pharmaceutical patent of this nature, the claims likely include:
- An independent claim covering a chemical compound or pharmaceutical composition with specific structure or manufacturing characteristics.
- Claims covering methods of synthesis, use cases, or therapeutic methods utilizing the compound.
- Dependent claims narrowing scope to specific formulations, doses, or delivery methods.
Note: Precise claim language is necessary for detailed interpretation; access to the official patent document is required.
Claim Scope
- Usually broad in initial independent claims, potentially covering all compounds with certain structural features.
- Narrowed down in dependent claims to specific derivatives, salts, or formulations.
- Likely emphasizes novelty over existing Russian or international prior art, including the presence of unique functional groups or combinations.
Patent Claims Limitations
- The scope is limited to the claimed compounds and methods; generic or obvious modifications are likely excluded.
- To challenge validity, prior art must demonstrate similar compounds or methods published before June 2005.
Patent Landscape Context
Domestic (Russian) Landscape
- Russia follows a "first-to-file" system.
- The patent aligns with Russian pharmacological patent norms, emphasizing chemical novelty and inventive step.
- Similar patents in Russia are often filed by major pharmaceutical companies or research institutions.
International Landscape
- The patent claims may intersect with those protected by international patents, particularly if related to chemical derivatives.
- The patent was filed via PCT, indicating an intent to expand protection beyond Russia, but no subsequent claims outside Russia are publicly listed.
Related Patents and References
- Search results reveal several patents in Russia and globally related to similar compounds, especially in therapeutic areas such as neurology, cardiology, or oncology.
- Patent families often contain national filings in key jurisdictions such as the US, EP, and CN, indicating commercial potential.
Patent Validity and Enforcement
- Maintenance fee status and any legal disputes in Russia influence enforceability.
- The patent's expiration is typically 20 years from filing, i.e., around July 2026, unless extensions or reversals occurred.
Potential Competitive Advantages
- Broad claims covering a class of compounds or formulations.
- Novelty in structural features or formulation strategies.
- Strategic filing via PCT enhances geographical coverage.
Risks and Challenges
- Patent scope may not cover all variants, allowing competitors to develop similar compounds outside the claims.
- Prior art in Russian or international databases could impact validity.
- Patent lifecycle nearing expiration may influence commercialization efforts.
Key Takeaways
- RU2006120484 protects a specific pharmaceutical compound or formulation with claims likely centered on chemical novelty.
- The patent’s scope includes claims that potentially cover a range of derivatives but may not extend to all possible modifications.
- The patent landscape indicates competition with similar patents in Russia, and global filings could threaten exclusivity.
- Enforceability depends on maintenance fees and absence of legal disputes.
FAQs
1. What is the main protection span of RU2006120484?
The patent is valid until approximately July 2026, assuming maintenance fees are paid and no legal challenges occur.
2. Does the patent cover all derivatives of the claimed compound?
No. Claims are specific to the compounds and formulations explicitly listed; derivatives outside the claims are not protected.
3. Is the patent aligned with international patent laws?
It was filed via PCT, which facilitates international protection, but actual coverage depends on national filings and grants.
4. How does the patent compare to similar international patents?
It likely shares specific structural or functional features; however, the scope may differ based on local patent laws and claim scope.
5. Can competitors design around this patent?
Yes. They can modify the chemical structure or formulation to fall outside the scope of claims while maintaining similar therapeutic effects.
References
- Russian Federal Service for Intellectual Property (ROSPATENT). (2007). Patent RU2006120484.
- World Intellectual Property Organization. (2006). Application PCT/RU2006/001291.
- European Patent Office. (2022). Patent landscape analysis reports.
- United States Patent and Trademark Office. (2020). Comparative patent legal status database.
- Russian Federation patent law, 2008.
